ARIA: Summary for ARIAD Pharmaceuticals, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 2:17pm EST - Canadian Markets close in 1 hour and 43 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Ariad Pharmaceuticals Inc. (ARIA)

At 14:02 EST: 2.28 USD

0.01 (0.44%)

MORE ON ARIA

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

ARIAD Pharmaceuticals, Inc. (NGM:ARIA) Delayed quote data

Last Trade:	2.28 USD
Trade Time:	2:02PM EST
Change:	0.01 (0.44%)
Prev Close:	2.27
Open:	2.26
Bid:	2.27 x 5000
Ask:	2.28 x 4000
1y Target Est:	8.85

Day's Range:	2.22 - 2.28
52wk Range:	0.72 - 3.48
Volume:	550,691
Avg Vol (3m):	2,723,450
Market Cap:	248.42M
P/E (ttm):	N/A
EPS (ttm):	-0.85
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add ARIA to Portfolio

Download Data

HEADLINES

•	Become a Recessionista? Not in This Stock Market
	TradingMarkets.com (Mon, Nov 23)

•	ARIAD to Present Data on Pan-BCR-ABL Inhibitor AP24534 at 51st American Society of Hematology Meeting
	Business Wire (Mon, Nov 23)

•	ARIAD PHARMACEUTICALS INC Financials
	EDGAR Online Financials (Fri, Nov 13)

•	Bristol Licenses Arthritis Drug: BioBuzz
	at TheStreet.com (Tue, Nov 10)

•	ARIAD to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
	Business Wire (Tue, Nov 10)

•	Celgene in the ASH Abstract Spotlight: BioBuzz
	at TheStreet.com (Tue, Nov 10)

•	Celgene in ASH Abstract Spotlight: BioBuzz
	at TheStreet.com (Tue, Nov 10)

•	ARIAD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Mon, Nov 9)

•	Monday Options Recap
	at Seeking Alpha (Mon, Nov 9)

•	Movers roundup: RadioShack, Abercrombie & Fitch
	AP (Mon, Nov 9)

•	Doc Offers Top Hep C Drug Picks: BioBuzz
	at TheStreet.com (Mon, Nov 9)

More Headlines for ARIA...

ANALYST

EPS Est (next year) (Dec-07) :	-0.81
EPS Est (in 2 years) (Dec-08) :	-0.89
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

ARIAD Pharmaceuticals, Inc. engages in the discovery and development of medicines to treat cancers by regulating cell signaling with small molecules in the United States.

Full Company Profile

Add to Portfolio

Email to a Friend

•